Naldi L, Catalano M, Melica M, Polvani S, Papini D, Landini I
Sci Rep. 2025; 15(1):8067.
PMID: 40055463
PMC: 11889168.
DOI: 10.1038/s41598-025-92674-6.
Jin B, Miao Z, Pan J, Zhang Z, Yang Y, Zhou Y
Cancer Cell Int. 2025; 25(1):78.
PMID: 40045411
PMC: 11881340.
DOI: 10.1186/s12935-025-03698-x.
Deng Z, Guo J, Zhu Z, Qing Q, Wan D, Lei P
Toxicol Res (Camb). 2025; 14(1):tfae202.
PMID: 40012843
PMC: 11851483.
DOI: 10.1093/toxres/tfae202.
Fang C, Zeng Z, Ye J, Ni B, Zou J, Zhang G
Stem Cell Res Ther. 2025; 16(1):95.
PMID: 40001265
PMC: 11863768.
DOI: 10.1186/s13287-025-04220-w.
Chen L, Xu H, Liu R, Yao Z, Xie Q, Zhang X
Poult Sci. 2025; 104(4):104923.
PMID: 39987600
PMC: 11904538.
DOI: 10.1016/j.psj.2025.104923.
Homoharringtonine: mechanisms, clinical applications and research progress.
Wang W, He L, Lin T, Xiang F, Wu Y, Zhou F
Front Oncol. 2025; 15:1522273.
PMID: 39949739
PMC: 11821653.
DOI: 10.3389/fonc.2025.1522273.
SLC1A4 Promotes Malignant Transformation of Hepatocellular Carcinoma by Activating the AKT Signaling.
Zheng J, Gong J
Anal Cell Pathol (Amst). 2025; 2025:1115184.
PMID: 39949345
PMC: 11824774.
DOI: 10.1155/ancp/1115184.
Catalase-Knockout Complements the Radio-Sensitization Effect of Titanium Peroxide Nanoparticles on Pancreatic Cancer Cells.
Tasia W, Washio A, Yamate K, Morita K, Mori Y, Kahar P
Molecules. 2025; 30(3).
PMID: 39942733
PMC: 11820024.
DOI: 10.3390/molecules30030629.
NCAPD3-mediated AKT activation regulates prostate cancer progression.
Zhang Y, Xie W, Zong X, Fang Y, Ren J, Jing Z
FASEB Bioadv. 2025; 7(2):e1488.
PMID: 39917394
PMC: 11795278.
DOI: 10.1096/fba.2024-00073.
Carboxylesterase 4A Inhibits the Malignant Biological Behavior of Nasopharyngeal Carcinoma via the PI3K/AKT Pathway.
Chen Q, Hao Q, Yang Y, Li L, Li D, Zhao R
Technol Cancer Res Treat. 2025; 24:15330338251319144.
PMID: 39912257
PMC: 11800256.
DOI: 10.1177/15330338251319144.
Current landscape and future directions of therapeutic approaches for adenoid cystic carcinoma of the salivary glands (Review).
Stawarz K, Durzynska M, Galazka A, Gorzelnik A, Zwolinski J, Paszkowska M
Oncol Lett. 2025; 29(3):153.
PMID: 39898287
PMC: 11782928.
DOI: 10.3892/ol.2025.14899.
Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy.
Chen Y, Jiang M, Li L, Yang S, Liu Z, Lin S
Cell Death Dis. 2025; 16(1):49.
PMID: 39870644
PMC: 11772762.
DOI: 10.1038/s41419-025-07367-9.
Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation.
Zhang S, Xing Z, Ke J
J Bone Oncol. 2025; 50():100655.
PMID: 39850453
PMC: 11755076.
DOI: 10.1016/j.jbo.2024.100655.
Inhibiting miR-155-5p promotes proliferation of human submandibular gland epithelial cells in primary Sjogren's syndrome by negatively regulating the PI3K/AKT signaling pathway PIK3R1.
Zhang Y, Wan L, Fang H, Li F, Wang L, Li K
Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(1):65-71.
PMID: 39819714
PMC: 11744292.
DOI: 10.12122/j.issn.1673-4254.2025.01.09.
IGF2BP3 curbed by miR-15c-3p restores disrupted lipid storage and progesterone secretion in chicken granulosa cells under oxidative stress through AKT-Raf1-ERK1/2 signaling pathway.
Lin Z, Gong Y, Yu C, Yang C, Yin L, Zhang D
Poult Sci. 2025; 104(2):104761.
PMID: 39754922
PMC: 11758555.
DOI: 10.1016/j.psj.2024.104761.
Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer.
Jiang M, Fang H, Tian H
Theranostics. 2025; 15(1):155-188.
PMID: 39744225
PMC: 11667227.
DOI: 10.7150/thno.103376.
The therapeutic potential of RNA m(6)A in lung cancer.
Yu J, Sun W, Zhao X, Chen Y
Cell Commun Signal. 2024; 22(1):617.
PMID: 39736743
PMC: 11687105.
DOI: 10.1186/s12964-024-01980-5.
Investigating the biomarker potential and molecular targets of TIGD1 in lung cancer using bioinformatics.
Bal Albayrak M, Korak T, Kasap M, Akpinar G
Turk J Med Sci. 2024; 54(6):1369-1380.
PMID: 39734333
PMC: 11673667.
DOI: 10.55730/1300-0144.5920.
AKT1-Mediated NOTCH1 phosphorylation promotes gastric cancer progression via targeted regulation of IRS-1 transcription.
Zhou L, Yang Y, Qiao Q, Mi Y, Gan Y, Zheng Y
J Cancer Res Clin Oncol. 2024; 151(1):15.
PMID: 39724412
PMC: 11671552.
DOI: 10.1007/s00432-024-06039-z.
CST1 promoted gastric cancer development by activating the AKT pathway.
Zhang L, Wang D, Zhang L, Zhu L
Clinics (Sao Paulo). 2024; 80():100561.
PMID: 39721372
PMC: 11729673.
DOI: 10.1016/j.clinsp.2024.100561.